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A complex interaction between genetic and environ-
mental risk factors has often been a suspected trigger for 
the development of neurodegenerative disease. Yet of all 
the possible environmental risk factors put forth, trauma 
to the central nervous system is one of the most consis-
tent candi  dates for initiating the molecular cascades that 
result in Alzheimer’s disease (AD), Parkinson’s disease 
(PD), and amyotrophic lateral sclerosis [1-3]. Recent 
evidence also suggests that mild traumatic brain injury 
(TBI), including repetitive concussive and subconcussive 
trauma, can provoke another distinctive neurodegenera-
tion: chronic traumatic encephalopathy (CTE) [4].
CTE has to date only been described neuro  patho-
logically in individuals with a history of repetitive closed 
head injury, most often occurring in the context of 
contact sports. It remains to be determined whether 
there is a genetic susceptibility to the development of 
CTE and whether a single severe traumatic head injury 
may also be causative.
Chronic traumatic encephalopathy
CTE is a progressive tauopathy with a distinct clinical 
and neuropathological proﬁ  le that becomes symptomatic 
many years after an individual experiences repeated con-
cussive or subconcussive blows to the head. Th  e  charac-
teristic features of CTE include: extensive tau immuno-
reactive neuroﬁ   brillary tangles and astrocytic tangles 
throughout the frontal and temporal cortices in a patchy, 
superﬁ   cial distribution, with focal epicenters at the 
depths of sulci and around small vessels; extensive tau 
neuroﬁ   brillary tangles in the limbic and paralimbic 
regions, diencephalon, basal ganglia and brainstem; and a 
relative paucity of β-amyloid (Aβ) deposits, although 
diﬀ  use plaques are present in roughly one-half of the 
cases. In advanced disease, there are also macroscopic 
abnor  malities: generalized cerebral atrophy and enlarged 
ventricles; atrophy of the medial temporal lobe structures 
and mammillary bodies; cavum septi pellucidi, often with 
fenestrations; and pallor of the substantia nigra.
CTE typically becomes symptomatic in mid-life as 
disordered cognition, most pronounced in the areas of 
memory and executive functioning; disturbances in mood 
and comportment (for example, apathy, irritability); and 
Parkinsonian signs [4]. CTE was in the past referred to as 
dementia pugilistica, which reﬂ   ected the prevailing 
notion that this condition was restricted to boxers – 
athletes who engaged in a sport with purposeful repeated 
blows to the head. Recent research, however, has demon-
strated neuropathological evidence of CTE in retired 
American football players, a professional wrestler, a 
professional hockey player and a soccer player [4], as well 
as in nonathletes [5]. It is probable that many individuals 
are susceptible to CTE, including those who experience 
falls, motor vehicle accidents, assaults, epileptic seizures, 
or military combat, and that repeated mild closed head 
trauma of diverse origin is capable of instigating the 
neurodegenerative cascade leading to CTE.
Although neuropathologically distinct, the clinical pre-
sen  tation of CTE may be very similar to AD or 
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advanced disease [4]. Individuals may meet clinical 
criteria for AD or frontotemporal lobar degeneration, 
even though the age of onset for CTE is generally younger 
than that for AD and the course of the disease is typically 
slower than that of AD or frontotemporal lobar 
degeneration. Th  ese similarities bring into question the 
speciﬁ  city of the clinical diagnostic criteria for AD used 
in the multitude of case–control studies that have 
established TBI as a risk factor for AD. Without 
neuropathological veriﬁ   cation, the prevalence of CTE 
neuropathology in a demented sample is unknown.
The link between head trauma, Alzheimer’s disease 
and other neurodegenerations
Multiple epidemiological studies have shown that mild 
TBI is a risk factor for late-life dementia, especially AD 
[1]. Although the evidence is not without its detractors 
(for example [6]), meta-analytic studies support the 
notion that AD risk is increased after TBI, at least for 
men [7]. In almost all of the studies investigating TBI and 
AD risk, AD was diagnosed based on clinical criteria for 
probable or possible AD, without neuropathological 
veriﬁ    cation. Only one study has evaluated the risk of AD 
following TBI using standardized neuropathological 
criteria for AD [8] – ﬁ  nding that a history of TBI was a 
risk factor for AD, particularly in individuals without the 
apolipoprotein e4 allele. As the majority of reports were 
based on clinical diagnostic criteria that may lack the 
speciﬁ  city to rule out other causes of dementia [9], it is 
possible that the increased incidence of dementia follow-
ing head injuries is due to CTE, alone or in conjunction 
with other neuro  degenerative conditions such as AD.
Multiple studies have also indicated that a history of 
trauma to the central nervous system is a risk factor for 
other neurodegenerative conditions, including PD [2,10] 
and amyotrophic lateral sclerosis [3,11,12]. Widespread 
TAR DNA-binding protein 43 (TDP-43)-positive inclu-
sions have been reported in the neocortex in cases of 
CTE [13]. We recently also found TDP-43 immuno-
reactive inclusions and neurites in the frontal and 
temporal cortices, medial temporal lobe, basal ganglia, 
diencephalon, and brainstem in 10 out of 12 cases of 
CTE. Th  ree of these athletes with CTE also had a 
progressive motor neuron disease characterized by 
profound weakness, atrophy, spasticity, and fascicula-
tions, and abundant TDP-43-positive inclusions were 
found in the spinal cord, as well as tau neuroﬁ  brillary 
changes, upon postmortem examination [14].
Th  ese  ﬁ  ndings support epidemiologic evidence that the 
repetitive head trauma experienced in sports might also 
be associated with the development of a motor neuron 
disease [3,11,14]. TBI could conceivably trigger multiple 
molecular pathways that result in the overproduction 
and aggregation of a number of key proteins that form 
pathological aggregates in neurodegenerative diseases. 
TBI may not only provoke the accumulation of hyper-
phosphorylated tau protein, as CTE, but also of Aβ, α-
synuclein, and TDP-43, possibly increasing the likelihood 
of developing AD, PD, and motor neuron disease. 
Experimental evidence indicates that Aβ neurotoxicity is 
enhanced in the presence of tau [15]. It is conceivable 
that tau deposition provoked by repetitive head trauma 
accelerates Aβ toxicity in individuals with age-related Aβ 
plaques [16], triggering the more rapid onset of AD. 
Further  more, aggregates of α-synuclein and Aβ have 
been described after experimental TBI in animals and 
after acute brain trauma in humans [17].
The need for future chronic traumatic 
encephalopathy research
Th   ere is clearly a need for improved accuracy of clinical 
diagnostic criteria in the diﬀ  erential diagnosis of CTE 
and AD, which will require new prospective longitudinal 
studies terminating in autopsy. Equally important is the 
need for standardized criteria to diagnose CTE neuro-
patho  logi  cally, either alone or as mixed disease.
Although the evidence suggests that central nervous 
system trauma is a risk factor for CTE, as well as for AD, 
PD, and motor neuron disease, very little is known about 
what type, frequency, or amount of trauma is necessary 
to induce the accumulation of these pathological proteins. 
Future prospective studies will be necessary to answer 
these questions as well as to determine at what age the 
nervous system is most susceptible to the deleterious 
eﬀ  ects of trauma and whether proper management of 
acute head injuries is eﬀ  ective in reducing the incidence 
of late-life neurodegenerative dementias.
Accurate diﬀ   erential diagnosis in the preclinical or 
early phases of CTE and AD may have important thera-
peutic implications as well. For example, therapeutics 
selectively targeting Aβ will be misguided if the 
predominant neuropathological abnormality is hyper-
phos  phorylated tau protein, as in CTE. Furthermore, use 
of experimental models of head injury to provoke 
neurodegeneration in genetically modiﬁ  ed animals may 
ultimately serve to identify key components of the patho-
genetic molecular cascades as well as susceptibility genes 
for a variety of neurodegenerative diseases.
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